FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
XPECT FLU A & B
K Number: K092423
·
Decision Aug 26, 2009
Classifications
1
FEI Numbers
36
Registration Numbers
36
Same Product Code
71
Applicant Total
64
Review Days
19
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- XPECT FLU A & B
- K Number
- K092423
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 866.3328
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Thermo Fisher Scientific
- Date Received
- August 7, 2009
- Decision Date
- August 26, 2009
- Product Code
- PSZ
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PSZ | Devices Detecting Influenza A, B, And C Virus Antigens | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (PSZ), ordered by most recent decision date.
Nano-Check Influenza A+B Test
FDA 510(k)
FDA Class 2
·Microbiology
Innovita Flu A/B Antigen Rapid Test
FDA 510(k)
FDA Class 2
·Microbiology
Acucy® Influenza A&B Test with the Acucy® 2 System
FDA 510(k)
FDA Class 2
·Microbiology
BD Veritor System for Rapid Detection of Flu A+B CLIA Waived Kit
FDA 510(k)
FDA Class 2
·Microbiology
BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived Kit
FDA 510(k)
FDA Class 2
·Microbiology
Osom Ultra Plus Flu A&B Test Kit
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by Thermo Fisher Scientific
| K Number | Device Name | ||
|---|---|---|---|
| K252062 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL | Sep 25, 2025 | Substantially Equivalent |
| K250575 | The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL | Sep 5, 2025 | Substantially Equivalent |
| K252014 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL | Aug 28, 2025 | Substantially Equivalent |
| K250990 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL | Jun 30, 2025 | Substantially Equivalent |
| K242843 | The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mL. | Jun 20, 2025 | Substantially Equivalent |
| K242659 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mL | May 22, 2025 | Substantially Equivalent |
| K242658 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL | Apr 15, 2025 | Substantially Equivalent |
| K243738 | The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL | Feb 27, 2025 | Substantially Equivalent |
| K243201 | The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dilution range of 0.015-32 ug/mL | Feb 10, 2025 | Substantially Equivalent |
| K242905 | The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.12-32 ug/mL | Feb 10, 2025 | Substantially Equivalent |